SOL company profile

SOL · Borsa Italiana · EUR

Compare SOL
€64.60Change from previous close: −2.27%Absolute change: −€1.50

Close · November 17, 2026

Company profile

SOL has 8,000 employees and is headquartered in Monza, Italy.

Its sales reach Italian and foreign markets, where it supplies gases, equipment and services to factories as well as to hospitals and care providers. Industrial offerings span oxygen, nitrogen, argon, hydrogen, carbon dioxide and liquefied natural gas, alongside high purity and electronics gases. The healthcare arm covers medical gases, respiratory and infusion therapies, hospital hygiene, telemedicine and digital services. Specialised units add CRYOLAB, which handles biological samples, DIATHEVA, which develops monoclonal antibodies and molecular kits, and PERSONAL GENOMICS for precision medicine.

In the fiscal year ended 31 December 2025, revenue reached 1.8 billion euro, up 10.0% on the previous year, and net profit came to 167.0 million euro. The group employed 8,000 people and is headquartered in Monza, Italy, where it was set up in 1927. SOL S.p.A. is a subsidiary of Gas And Technologies World B.V.

Company facts

Sector
Materials
Industry
Specialty Chemicals
Country
Italy
Headquarters
Via Borgazzi, 27, 20900, Monza
Employees
8,000
Founded
1927
Fiscal year
January - December
Listing
SOL · Borsa Italiana
Currency
EUR
ISIN
IT0001206769

SOL and its competitors

The most similar companies by business and size

CompanyCountryMarket capEmployeesOperating marginP/E (trailing 12 months)
SOLSOLItaly$6.58B8,00015.1%34.6
Croda InternationalCRDAUnited Kingdom$6.81B5,9547.3%64.4
IMCDIMCDNetherlands$6.83B5,2378.1%27.1
FUCHSFPEGermany$5.91B7,21313.1%17.2
ArkemaAKEFrance$4.94B20,7004.6%234.8
Wacker ChemieWCHGermany$4.41B15,9165.1%—

Competitors: same or related industry, same region first, then the closest market capitalization. Market cap converted into US dollars at the latest exchange rates; P/E over the last 12 months, not shown when negative.

Compare SOL with its competitors